Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 
Australian Consumer Sentiment Slumps in Early December as Inflation Fears Resurface 
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now 
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand 
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing 
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast 
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman 
Asian Technology and Chipmaking Stocks Slide as AI Spending Concerns Shake Markets 
Asian Currencies Trade Sideways as Dollar Weakens Ahead of Key U.S. Data 
FDA Pilot Program Eases Rules for Nicotine Pouch Makers 
Bank of Korea Downplays Liquidity’s Role in Weak Won and Housing Price Surge 
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
A new diagnostic method that ascertains if a person is suffering from Parkinson’s disease or dementia by looking at the manner of walking has been patented.
A new diagnostic technique developed by a St. Mary's Hospital research team in Uijeongbu has been patented and put up for patent registration, which analyses data from an individual's shoes to detect neurological disorders.
Most degenerative brain disorders, such as Parkinson's disease, dementia, and Lou Gehrig's disease, occur at an older age.
Currently, a costly MRI or a PET scan is required for such diagnosis, as well as frequent visits to the hospital.
The new approach, on the other hand, employs a "smart insole" that is placed inside a shoe and collects data from its sensors, which is then analyzed to assess the brain health of the wearer.
The new technique achieved an accuracy of 98.1 percent for the diagnosis of Parkinson's disease, as well as 83.2 percent for differentiating whether an illness is vascular or degenerative.
